Neuropsychiatric manifestations of multiple sclerosis

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 10, Issue 4, 2008, Pages 318-324

  Politte, Laura C ^a,b,f   Huffman, Jeff C ^c,d   Stern, Theodore A ^c,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c Department of Psychiatry

^d MGH ^*

^e Psychiatric Consultation Service

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BETA1A INTERFERON; CHOLINESTERASE INHIBITOR; CITALOPRAM; CORTICOSTEROID; DESIPRAMINE; DEXTROMETHORPHAN; DONEPEZIL; ESCITALOPRAM; GLATIRAMER; INTERFERON BETA SERINE; LITHIUM CARBONATE; METHYLPREDNISOLONE; MODAFINIL; MOOD STABILIZER; OLANZAPINE; QUETIAPINE; QUINIDINE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; VENLAFAXINE; ZIPRASIDONE;

AGITATION; ANXIETY; ARTICLE; BIPOLAR DISORDER; BLURRED VISION; COGNITIVE DEFECT; COGNITIVE THERAPY; DEPRESSION; DIPLOPIA; DISTRACTIBILITY; DYSPHAGIA; DYSPHORIA; FATIGUE; GAIT DISORDER; HUMAN; IMPULSIVENESS; IRRITABILITY; MAJOR DEPRESSION; MANIA; MEMORY DISORDER; MENTAL DISEASE; MIXED MANIA AND DEPRESSION; MOOD CHANGE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; PSEUDOBULBAR PALSY; PSYCHOSIS; SHORT TERM MEMORY; SLEEP DISORDER; SPEECH DISORDER; SUICIDAL IDEATION; SUICIDE; URINE INCONTINENCE; URINE RETENTION; VERTIGO; WEAKNESS;

EID: 49449095665     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.v10n0408     Document Type: Article

References (32)

1. Caplan JP, Cassem NH, Murray GB, et al. Delirium. In: Stern TA, Rosenbaum JF, Fava M, et al, eds. Massachusetts General Hospital Comprehensive Clinical Psychiatry. Philadelphia, Pa: Mosby/Elsevier; 2008:217-229
2. Rubin E, Farber JL, eds. Pathology. 3rd ed. Philadelphia Pa: Lippincott-Raven; 1999:1496-1498
3. Calabresi PA. Diagnosis and management of multiple sclerosis. Am Fam Physician 2004;70:1935-1944
4. Sanfilipo MP, Benedict RHB, Weinstock-Guttman B, et al. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 2006;66:685-692
5. Rovaris M, Giancarlo C, Massimo F. MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction. J Neurol Sci 2006;245:111-116
6. Portaccio E, Amato MP, Bartolozzi ML, et al. Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment. J Neurol Sci 2006;245:195-199
7. Hurley RA, Taber KH, Zang J, et al. Neuropsychiatric presentation of multiple sclerosis. J Neuropsychiatry Clin Neurosci 1999;11:5-7
8. Asghar-Ali AA, Taber KH, Hurley RA, et al. Pure neuropsychiatric presentation of multiple sclerosis. Am J Psychiatry 2004;161:226-231
9. Brosseau KM, Arciniegas DB, Carmosino MJ, et al. The differential diagnosis of Axis I psychopathology presenting to a university-based multiple sclerosis clinic. Mult Scler 2007;13:749-753
10. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001 Jul;50(1):121-127
11. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58:840-846
12. McGuigan C, Hutchinson M. Unrecognised symptoms of depression in a community-based population with multiple sclerosis. J Neurol 2006;253:219-223
13. Ghaffar O, Feinstein A. The neuropsychiatry of multiple sclerosis: a review of recent developments. Curr Opin Psychiatry 2007;20:278-285
14. Feinstein A. Neuropsychiatric syndromes associated with multiple sclerosis. J Neurol 2007 May;254 (suppl 2):II73-II76
15. Diaz-Olavarrieta C, Cummings JL, Velazquez J, et al. Neuropsychiatric manifestations of multiple sclerosis. J Neuropsychiatry Clin Neurosci 1999;11:51-57
16. Lynch SG, Kroencke DC, Denney DR. The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope. Mult Scler 2001;7:411-416
17. Patten SB, Beck CA, Williams JVA, et al. Major depression in multiple sclerosis: a population-based perspective. Neurology 2003;61:1524-1527
18. Chwastiak L, Ehde DM, Gibbons LE, et al. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 2002;159:1862-1868
19. Feinstein A, Roy P, Lobaugh N, et al. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004;62:586-590
20. Feinstein A. Multiple sclerosis, disease modifying treatments and depression: a critical methodological review. Mult Scler 2000;6:343-348
21. Krishnan KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med 2005;67:1-8
22. Panitch HS, Thisted RA, Smith RA, et al. Randomized, controlled trial of dextromethorphan/quinidine for the pseudobulbar affect in multiple sclerosis. Ann Neurol 2006;59:780-787
23. Patten SB, Svenson LW, Metz LM. Psychotic disorders in MS: population-based evidence of an association. Neurology 2005;65:1123-1125
24. Cader S, Cifelli A, Abu-Omar Y, et al. Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis. Brain 2006;129:527-537
25. Rovaris M, Giancarlo C, Massimo F. MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction. J Neurol Sci 2006;245:111-116
26. Calabrese P. Neuropsychology of multiple sclerosis-an overview. J Neurol 2006 Feb;253(suppl 1):I10-I15
27. Nocenti U, Pasqualetti P, Bonavita S, et al. Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Mult Scler 2006;12:77-87
28. Pantano P, Mainero C, Caramia F. Functional brain reorganization in multiple sclerosis: evidence from fMRI studies. J Neuroimaging 2006;16:104-114
29. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16(9):606-613
30. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State:" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3):189-198
31. Thomas PW, Thomas S, Hillier C. Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev 2006 Jan;(1):CD004431
32. Christodoulou C, Melville P, Scherl WF, et al. Effects of donepezil on memory and cognition in multiple sclerosis. J Neurol Sci 2006;245:127-136